AstraZeneca and Silence Therapeutics extend siRNA delivery collaboration
This article was originally published in Scrip
Executive Summary
AstraZeneca and Silence Therapeutics have agreed a one-year extension to their ongoing small interfering RNA (siRNA) delivery collaboration.